WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002032951) A NOVEL POLYPEPTIDE, A F-BOX PROTEIN 44.33 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/032951    International Application No.:    PCT/CN2001/001443
Publication Date: 25.04.2002 International Filing Date: 21.09.2001
Chapter 2 Demand Filed:    25.03.2002    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: BIOWINDOW GENE DEVELOPMENT INC. SHANGHAI [CN/CN]; 12th Floor, 3rd Building, No. 1111 Zhongshan Bei Er Rd., Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: WATSON & BAND LAW OFFICES; 61 Nanjing Rd (E), 11th floor, 200002 Shanghai (CN)
Priority Data:
00125325.5 22.09.2000 CN
Title (EN) A NOVEL POLYPEPTIDE, A F-BOX PROTEIN 44.33 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PROTEINE A BOITE MADS 44.33, ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a novel polypeptide, a F-box protein 44.33, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as diabetes, menstrual disturbance, peptic ulcer, arhythmia, hemosphthisis, epilepsia etc. The invention also discloses the agonistes against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the novel F-box protein 44.33.
(FR)L'invention concerne un nouveau polypeptide, une protéine à boîte MADS 44.33, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment du diabète, des troubles de la menstruation, d'ulcères gastroduodénaux, d'arythmies, d'anémies et d'épilepsies. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la protéine à boîte MADS 44.33.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)